Product Code: RP-ID-10321892 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10321892
Market Overview:
Global Prenatal and New-born Genetic Testing Market Size study, by Technology (Screening and Diagnostic), by Diseases (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle cell Anemia and Others), by End-Use (Hospitals, Maternity and Specialty Clinics and Diagnostic centers) and Regional Forecasts 2020-2026
Global Prenatal and New-born Genetic Testing Market is valued approximately USD 13.98 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9% over the forecast period 2019-2026. Prenatal and New-Born testing is an advanced technology used for genetic screening in the healthcare industry to identify the genetic or other birth defects in newborn baby at early stage. The test is conducted during time interval of pregnancy to determine the health of the fetus at an early stage and helps in identifying various genetic and chromosomal anomalies such as birth defects, gene mutations and cystic fibrosis etc. Therefore, such advent features of prenatal and new-born genetic testing helps parents to detect early abnormal diseases in fetus to take suitable treatment. Hence, rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder is expected to drive the growth of market over the forecast years. For instance: as per the World Health Organization, over an estimate 303000 newborns die within 4 weeks of birth every year globally due to the congenital anomalies. Also, as per the Centers of Diseases Control, birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year and is a leading cause of infant deaths, accounting for 20% of all infant deaths. Thus, increase in cases of birth defects in newborn baby and remarkable application of Prenatal and New-born Genetic Testing to identify it at an early stage are the factors accelerating the growth of market over the forecast years. However, lack of advanced infrastructure and skilled labor in developing region are the factors that hamper the growth of market.
The regional analysis of global Prenatal and New-born Genetic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share owing to the due to the rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as advancement in genetic screening technologies in the region would create lucrative growth prospects for the Prenatal and New-born Genetic Testing market across Asia-Pacific region.
Major market player included in this report are:
Abbott Laboratories
Agilent
AutoGenomics
Ariosa Diagnostics
Baebies
Berry Genomics Co. Ltd
BGI
Biocartis Group NV
Natera Inc.
Sequenom Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Diseases offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Screening
Diagnostic
By Diseases:
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle cell Anaemia
Others
By End-Use:
Hospitals
Maternity and Specialty Clinics
Diagnostic centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Prenatal and New-born Genetic Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Agilent
AutoGenomics
Ariosa Diagnostics
Baebies
Berry Genomics Co. Ltd
BGI
Biocartis Group NV
Natera Inc.
Sequenom Inc.
Related Reports
Proof of Quality & Reliability
